MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,092 | -98.7% | 5,223 | -96.8% | 0.00% | – |
| Q2 2023 | $244,867 | +89.3% | 163,244 | +117.0% | 0.00% | – |
| Q1 2023 | $129,372 | +52921.3% | 75,216 | +35379.2% | 0.00% | – |
| Q4 2022 | $244 | -93.9% | 212 | -82.3% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 1,200 | +0.1% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 1,199 | -24.4% | 0.00% | – |
| Q1 2022 | $8,000 | -20.0% | 1,586 | +0.1% | 0.00% | – |
| Q4 2021 | $10,000 | -52.4% | 1,584 | -46.4% | 0.00% | – |
| Q3 2021 | $21,000 | -44.7% | 2,956 | -51.3% | 0.00% | – |
| Q2 2021 | $38,000 | – | 6,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |